EGFR Exon 19 Deletion Mutation

Explore clinical trials studying EGFR Exon 19 Deletion Mutation. Study availability and eligibility vary by location and protocol.

4 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

EGFR Exon 19 Deletion Mutation trial results

Recruiting

NCT07563205

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
Locations: CH du Pays d Aix - Service des Maladies Respiratoires Aix-en-Provence, France

APHP Hôpital Avicennes Bobigny, France

Hôpital Louis Pradel Bron, France

Pneumologie Centre François Baclesse Caen, France

View all 16 locations

Recruiting

NCT06659458

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Our Lady of the Lake Regional Medical Center Baton Rouge, Louisiana, United States

Not Yet Recruiting

NCT07709585

Conditions: Advanced Non-small Cell Lung Cancer (NSCLC), EGFR Exon 19 Deletion Mutation, EGFR Exon 21 L858R Mutation, +6 more
Locations: Guangdong Provincial Hospital of Chinese Medicine Guangzhou, Guangdong, China

Completed

NCT01532089

Conditions: EGFR Exon 19 Deletion Mutation, EGFR NP_005219.2:p.L858R, Lung Non-Squamous Non-Small Cell Carcinoma, +1 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

Heartland Cancer Research NCORP Decatur, Illinois, United States

Illinois CancerCare-Peoria Peoria, Illinois, United States

Carle Cancer Center NCI Community Oncology Research Program Urbana, Illinois, United States

View all 19 locations